About 4 results found for searched term "Talizumab" (0.124 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M10890 | Spartalizumab | PD-1/PD-L1 |
| Spartalizumab (anti-PD-1) is a human-derived IgG4 antibody against PD-1 that inhibits the binding of PD-L1 and PD-L2 to PD-1. PDR001 binds to PD-1 with high affinity to inhibit its biological activity; MW: 145.8 KD. | ||
| M24843 | Natalizumab | Integrin |
| Natalizumab is a recombinant, humanized IgG4 monoclonal antibody, binds to α4β1-integrin and blocks its interaction with vascular cell adhesion molecule-1 (VCAM-1). Natalizumab can be used for the treatment of relapsing remitting multiple sclerosis and Crohn's disease. Natalizumab is also the first targeted therapy which blocks an essential mechanism for lymphocyte entry to the CNS and thus prevents acute demyelinating relapses. | ||
| M25222 | Talizumab | Others |
| TNX 901; Anti-Human IgE Fc Recombinant Antibody | ||
| Talizumab (TNX 901) is an anti-IgE humanized IgG1 monoclonal antibody. | ||
| M25308 | Rontalizumab | Others |
| RhuMab IFNalpha Anti-Human IFN alpha Recombinant Antibody | ||
| Rontalizumab is a humanized IgG1 monoclonal antibody targets IFN-α. Rontalizumab can be used for the research of systemic lupus erythematosus. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
